Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Capital Expenditures (2016 - 2025)

Healthstream (HSTM) has disclosed Capital Expenditures for 16 consecutive years, with -$3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 111.77% to -$3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $475000.0, a 98.22% decrease, with the full-year FY2025 number at $475000.0, down 98.22% from a year prior.
  • Capital Expenditures was -$3.0 million for Q4 2025 at Healthstream, down from $3.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $25.5 million in Q4 2024 to a low of -$17.4 million in Q4 2023.
  • A 5-year average of $1.7 million and a median of $810500.0 in 2023 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 1095.07% in 2025; the steepest drop was 163.95% in 2025.
  • Healthstream's Capital Expenditures stood at -$13.2 million in 2021, then dropped by 26.63% to -$16.7 million in 2022, then dropped by 4.12% to -$17.4 million in 2023, then skyrocketed by 247.2% to $25.5 million in 2024, then tumbled by 111.77% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Capital Expenditures are -$3.0 million (Q4 2025), $3.4 million (Q3 2025), and -$110000.0 (Q2 2025).